{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:56:56Z","timestamp":1793905016889,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773794"],"award-info":[{"award-number":["81773794"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974507"],"award-info":[{"award-number":["81974507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003819"],"award-info":[{"award-number":["82003819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.phymed.2021.153585","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:44:48Z","timestamp":1621831488000},"page":"153585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"87","author":[{"given":"Yongmei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-9706","authenticated-orcid":false,"given":"Zean","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153585_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118814","article-title":"Rationalizing the therapeutic potential of apigenin against cancer","volume":"267","author":"Ahmed","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2021.153585_bib0002","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2021.153585_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105209","article-title":"Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets","volume":"161","author":"Balakumar","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2021.153585_bib0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MNH.0000000000000619","article-title":"The role of uric acid in inflammasome-mediated kidney injury","volume":"29","author":"Braga","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.phymed.2021.153585_bib0006","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1039\/C6FO01561A","article-title":"Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-kappaB\/NLRP3 inflammasome activation via the AMPK\/SIRT1 pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2021.153585_bib0007","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1039\/C9FO00509A","article-title":"Effect of lemon water soluble extract on hyperuricemia in a mouse model","volume":"10","author":"Chen","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2021.153585_bib0008","first-page":"1103","article-title":"Characterizations of the urate transporter, GLUT9, and its potent inhibitors by patch-clamp technique","volume":"69","author":"Chen","year":"2020","journal-title":"SLAS Discov"},{"key":"10.1016\/j.phymed.2021.153585_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153374","article-title":"Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase","volume":"80","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153585_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153111","article-title":"Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption","volume":"66","author":"Cui","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153585_bib0011","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/biof.1590","article-title":"Thymoquinone attenuates oxidative stress of kidney mitochondria and exerts nephroprotective effects in oxonic acid-induced hyperuricemia rats","volume":"46","author":"Dera","year":"2020","journal-title":"Biofactors"},{"key":"10.1016\/j.phymed.2021.153585_bib0012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1681\/ASN.2009040406","article-title":"Homozygous SLC2A9 mutations cause severe renal hypouricemia","volume":"21","author":"Dinour","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phymed.2021.153585_bib0013","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phymed.2021.153585_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2016.07.003","article-title":"Protective role of apigenin in cisplatin-induced renal injury","volume":"789","author":"He","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153585_bib0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/jf5034834","article-title":"Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney","volume":"63","author":"Hong","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phymed.2021.153585_bib0016","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semnephrol.2020.01.004","article-title":"Wnt\/\u03b2-catenin in acute kidney injury and progression to chronic kidney disease","volume":"40","author":"Huffstater","year":"2020","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.phymed.2021.153585_bib0017","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopha.2017.04.031","article-title":"Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats","volume":"91","author":"Huijuan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2021.153585_bib0018","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-016-0587-7","article-title":"Urate handling in the human body","volume":"18","author":"Hyndman","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.phymed.2021.153585_bib0019","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the national kidney foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.phymed.2021.153585_bib0020","doi-asserted-by":"crossref","first-page":"F1327","DOI":"10.1152\/ajprenal.00272.2019","article-title":"Uric acid and inflammation in kidney disease","volume":"318","author":"Jung","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.phymed.2021.153585_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.4121","article-title":"Wnt signalling in kidney diseases: dual roles in renal injury and repair","volume":"229","author":"Kawakami","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.phymed.2021.153585_bib0022","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.semarthrit.2020.04.007","article-title":"The biology of urate","volume":"50","author":"Keenan","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phymed.2021.153585_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2020.00049","article-title":"Mangiferin ameliorates hyperuricemic nephropathy which is associated with downregulation of AQP2 and increased urinary uric acid excretion","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153585_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.032","article-title":"Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice","volume":"59","author":"Liang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153585_bib0025","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.biopha.2017.09.091","article-title":"Effects of apigenin pretreatment against renal ischemia\/reperfusion injury via activation of the JAK2\/STAT3 pathway","volume":"95","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2021.153585_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.phymed.2021.153585_bib0027","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","article-title":"Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-kappaB-TNF-alpha and TGF-beta1-MAPK-fibronectin pathways","volume":"313","author":"Malik","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.phymed.2021.153585_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","article-title":"An update on the genetic architecture of hyperuricemia and gout","volume":"17","author":"Merriman","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phymed.2021.153585_bib0029","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/bpb.30.1551","article-title":"Hypouricemic action of selected flavonoids in mice: structure-activity relationships","volume":"30","author":"Mo","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2021.153585_bib0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-019-2016-6","article-title":"Population-specific factors associated with fractional excretion of uric acid","volume":"21","author":"Narang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phymed.2021.153585_bib0031","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1038\/s41598-019-43241-3","article-title":"Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2021.153585_bib0032","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/15257770.2013.872274","article-title":"Hyperuricemia in hematologic malignancies is caused by an insufficient urinary excretion","volume":"33","author":"Oka","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.phymed.2021.153585_bib0033","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bmcl.2015.12.040","article-title":"Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model","volume":"26","author":"Peng","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2021.153585_bib0034","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.apsb.2017.05.004","article-title":"Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice","volume":"8","author":"Qin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2021.153585_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phymed.2021.153585_bib0036","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/ijms20061305","article-title":"The therapeutic potential of apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2021.153585_bib0037","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/1440-1681.13355","article-title":"Salidroside protects against diabetes mellitus-induced kidney injury and renal fibrosis by attenuating TGF-beta1 and Wnt1\/3a\/beta-catenin signalling","volume":"47","author":"Shati","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phymed.2021.153585_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173570","article-title":"Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy","volume":"887","author":"Shi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153585_bib0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","article-title":"Safety and tolerability of available urate-lowering drugs: a critical review","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phymed.2021.153585_bib0040","doi-asserted-by":"crossref","first-page":"F660","DOI":"10.1152\/ajprenal.00480.2018","article-title":"Blockade of ERK1\/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy","volume":"316","author":"Tao","year":"2019","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.phymed.2021.153585_bib0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41538-020-0063-7","article-title":"Inhibitory effect of Citrus flavonoids on the in vitro transport activity of human urate transporter 1 (URAT1\/SLC22A12), a renal re-absorber of urate","volume":"4","author":"Toyoda","year":"2020","journal-title":"NPJ Sci. Food"},{"key":"10.1016\/j.phymed.2021.153585_bib0042","article-title":"Apigenin suppresses TGF-\u03b21-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1\u03b1 expression by miR-122-5p","volume":"85","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153585_bib0043","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/DDDT.S247091","article-title":"Treatment with a PPAR-gamma agonist protects against hyperuricemic nephropathy in a rat model","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phymed.2021.153585_bib0044","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1039\/C8FO01480A","article-title":"Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2021.153585_bib0045","doi-asserted-by":"crossref","first-page":"33421","DOI":"10.1021\/acsomega.0c05360","article-title":"Structural insights into the atomistic mechanisms of uric acid recognition and translocation of human urate anion transporter 1","volume":"5","author":"Zhao","year":"2020","journal-title":"ACS Omega"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:27:23Z","timestamp":1760552843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":44,"alternative-id":["S0944711321001276"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153585","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt\/\u03b2-catenin pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153585"}}